Search hospitals > Florida > Hialeah
Clinical Pharmacology of Miami
Claim this profileHialeah, Florida 33014
Global Leader in Healthy Subjects
Global Leader in Kidney Failure
Conducts research for Liver Disease
Conducts research for Diabetes
Conducts research for Type 2 Diabetes
226 reported clinical trials
3 medical researchers
Summary
Clinical Pharmacology of Miami is a medical facility located in Hialeah, Florida. This center is recognized for care of Healthy Subjects, Kidney Failure, Liver Disease, Diabetes, Type 2 Diabetes and other specialties. Clinical Pharmacology of Miami is involved with conducting 226 clinical trials across 141 conditions. There are 3 research doctors associated with this hospital, such as Alexander Prezioso, Alfredo Fernandez, and Ernesto Fuentes.Top PIs
Alexander PreziosoClinical Pharmacology of Miami1 year of reported clinical research
Studies Healthy Subjects
Studies Kidney Failure
3 reported clinical trials
2 drugs studied
Alfredo FernandezClinical Pharmacology of Miami1 year of reported clinical research
Studies Bunions
Studies Colorectal Cancer
3 reported clinical trials
3 drugs studied
Ernesto FuentesClinical Pharmacology of Miami4 years of reported clinical research
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
2 reported clinical trials
3 drugs studied
Clinical Trials running at Clinical Pharmacology of Miami
Non-alcoholic Fatty Liver Disease
Chronic Hepatitis D
Liver Disease
Fatty Liver Disease
Liver Failure
Obesity
Tourette Syndrome
Hepatitis D
Bunions
Healthy Subjects
Efinopegdutide
for Liver Disease
The purpose of this study is to evaluate the pharmacokinetics of efinopegdutide in participants with hepatic impairment compared to healthy participants, and to examine the safety and tolerability of efinopegdutide.
Recruiting1 award Phase 11 criteria
HTD1801
for Non-alcoholic Fatty Liver Disease
A phase 2b, multicenter, randomized, double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes mellitus or pre-diabetes.
Recruiting0 awards Phase 24 criteria
BI 3006337
for Fatty Liver Disease
This study is open to adults with overweight or obesity who also have fatty liver disease. The purpose of this study is to find the highest dose of BI 3006337 that people with overweight or obesity and with fatty liver disease can tolerate. Participants are divided into 4 groups of equal size randomly, which means by chance. Different doses of BI 3006337 are given to participants in each group. Participants in each group receive an injection of either BI 3006337 or placebo once a week. Placebo injections look like BI 3006337 injections but do not contain any medicine. Participants are in the study for about 4 months. During this time, they visit the study site 18 times. Three of the visits include overnight stays at the study site. The doctors check the health of the participants and note any health problems that could have been caused by BI 3006337.
Recruiting0 awards Phase 16 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Clinical Pharmacology of Miami?
Clinical Pharmacology of Miami is a medical facility located in Hialeah, Florida. This center is recognized for care of Healthy Subjects, Kidney Failure, Liver Disease, Diabetes, Type 2 Diabetes and other specialties. Clinical Pharmacology of Miami is involved with conducting 226 clinical trials across 141 conditions. There are 3 research doctors associated with this hospital, such as Alexander Prezioso, Alfredo Fernandez, and Ernesto Fuentes.